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We compared the profile of histone H1 kinase activity, reflecting Maturation Promoting Factor (MPF) activity in oocytes bisected at the
germinal vesicle (GV) stage and allowed to mature as separate oocyte halves in vitro. Whereas the oocyte halves containing the nucleus exhibited
the same profile of increased kinase activity as that typical for intact oocytes, the anuclear halves revealed strong inhibition of the increase in this
activity soon after germinal vesicle breakdown (GVBD). In contrast, the profile of MAP kinase activity did not differ significantly between
anuclear and nucleus-containing oocyte halves throughout maturation. Of the two MPF components, CDK1 and cyclin B1, the amount of the latter
was significantly reduced in anuclear halves, a reduction due to low-level synthesis and not to enhanced degradation. Expression of three reporter
luciferase RNAs constructed, respectively, to contain cyclin B1-specific 3′UTR, the globin-specific 3′UTR, or no 3′UTR sequence was enhanced
in nuclear halves, with significantly greater enhancement for the construct containing cyclin B1-specific 3′UTR as compared to the two other
RNAs. We conclude that the profile of activity of MPF during mouse oocyte maturation is controlled by an unknown GV-associated factor(s)
acting via 3′UTR-dependent control of cyclin B1 synthesis. These results require the revision of the hitherto prevailing view that the control of
MPF activity during mouse oocyte maturation is independent of GV-derived material.
© 2006 Elsevier Inc. All rights reserved.Keywords: Mouse oocyte; Meiotic maturation; GV-associated factor(s); MPF; MAP kinase; Cyclin B1; mRNA; Translational controlIntroduction
Meiosis in mouse oocytes starts synchronously in the fetal
ovary and becomes arrested at the first prophase, around the time
of birth. During each estrus cycle in adult female mice, a group
of oocytes resumes meiosis and progresses through meiotic
maturation until second metaphase (MII), when cell cycle
progression is again blocked, and the oocytes are ovulated for
future fertilization. Meiotic maturation is controlled primarily by
maturation-promoting factor (MPF) and cytostatic factor (CSF)
(Masui and Markert, 1971). MPF is a heterodimer formed from⁎ Corresponding author. Department of Developmental Biology, Max Planck
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doi:10.1016/j.ydbio.2005.12.052the enzymatic protein kinase component—CDK1 kinase and the
regulatory one—cyclin B. In oocytes, as in other cell types, MPF
functions mainly to ensure entry into and maintenance of the M-
phase of the cell cycle. CSF activity is unique to oocytes and acts
to arrest meiotic progression at MII. The Mos/MAP kinase
pathway is a major component of CSF (Colledge et al., 1994;
Hashimoto et al., 1994; Verlhac et al., 1996), although it is not
clear how this pathway inhibits MPF inactivation and onset of
anaphase II. CSF is abolished during a two-step process by
fertilizing sperm or parthenogenetic stimuli, allowing entry into
second meiotic anaphase and progression to interphase of the
first embryonic cell cycle (Ciemerych and Kubiak, 1999).
Studies of the nucleo-cytoplasmic interactions in the mouse
oocyte have revealed a key role for components of the prophase
nucleus, i.e., the germinal vesicle (GV), in the control of meiotic
maturation. Such components, mixed with oocyte cytoplasm
upon entry into the first meiotic M-phase (germinal vesicle
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(Polanski et al., 1998) and the ability to remodel sperm nuclei
after fertilization (Balakier and Tarkowski, 1980; Borsuk, 1991).
With respect to cell cycle control, the influence of GV material
onMPF activation has been demonstrated in starfish (Picard and
Doree, 1984), salamander Pleurodeles (Skoblina et al., 1984)
and axolotl (Gautier, 1987). In frog oocytes, initial reports based
on biological assays suggested the cytoplasmic control of MPF
activity (Masui and Markert, 1971; Schorderet-Slatkine and
Drury, 1973), whereas a later study based on kinase activity
measurements revealed an abnormal profile of MPF activity
during maturation of Xenopus oocytes deprived of GV-material
(Iwashita et al., 1998), although the latter finding remains
controversial (Fisher et al., 1998). Like the initial Xenopus report
(Schorderet-Slatkine and Drury, 1973), the only study in the
mouse relying on a biological assay described the cytoplasmic
control of MPF activity (Balakier and Czolowska, 1977). In the
present study, we re-examined this issue in mouse oocytes using
biochemical measurements of MPF and MAP kinase activity as
well as quantitative analyses of cyclin B1 gene expression
system combined with biological tests for MPF and CSF
activities. We show that full activation of MPF in maturing
oocyte depends on a GV-associated factor(s), which regulates
cyclin B1 synthesis through 3′UTR-located mRNA sequences.
Materials and methods
Oocyte isolation, micromanipulation and culture
Adult female mice from outbred strain OF1 were used as the source of
oocytes. Isolation of GV-stage oocytes and their in vitro maturation was carried
out as described (Polanski et al., 2005) in M2 culture medium (Fulton and
Whittingham, 1978). Isolation and micromanipulation were performed in
medium supplemented with dbcAMP to inhibit resumption of meiotic
maturation (Cho et al., 1974).
To enable oocyte bisection zona pellucidawas removed by brief exposure to
0.25% of pronase (B grade, Calbiochem). Zona-free oocytes were placed in M2
medium containing cytochalasin D (Sigma, 1 μg/ml) for 15–30 min, moved to
agar-coated Petri dishes, and bisected as described (Tarkowski, 1977). Only the
genuine sister nuclear and anuclear halves were used in this study, i.e., when cuts
produced from a single oocyte were not equal in size or when one of the halves
did not survive bisection, they were discarded.
RNA injection into GVoocytes was performed as described (Tsurumi et al.,
2004). Injected oocytes were allowed to recover in culture for 1–2 h before
removal of the zona pellucida and bisection.
Meiotic maturation was induced by rinsing out the dbcAMP and cytochalasin
D and subsequent culture in drug-free M2 medium. Oocyte sister halves used for
kinase assay or luciferase-based determination of translational activity were
cultured in separate drops to verify their origin and, in turn, enable comparison of
kinase activity or luciferase translation in sister pairs originating from the same
oocyte. For Western blotting and immunoprecipitation, oocyte halves were
cultured in groups. In some experiments, the halves were cultured in the presence
of 5 μMof the proteosome inhibitor lactacystin (Sigma) starting at 2 h after GVBD.
Kinase assay
Samples were collected in 1 μl of distilled water supplemented with BSA
(fraction V, Sigma, 20 mg/ml) at specific time points of maturation and frozen at
−70°C. For each sample composed of 4 nuclear halves, the sister anuclear
sample derived from the same respective oocytes was collected at the same time
point. Histone H1 kinase and myelin basic protein (MBP) kinase activity were
assessed as a measure of MPF and MAP kinase activity, respectively, in
combined assay as described (Verlhac et al., 1996).Biological assay of MPF activity
Oocyte halves were fused with reporter GV-stage oocytes and assessed for
MPF activity based on the ability of the half to induce GVBD (entry into M-
phase) after fusion. Briefly, zona-free GV-stage oocytes and oocyte halves that
had undergone maturation in vitro (as indicated by first polar body extrusion by
nuclear sister halves) were placed in medium containing 400 μg/ml
phytohaemagglutinin (PHA-M, Sigma). Individual whole oocytes were
agglutinated with individual oocyte halves, and fusion was induced by
polyethylene glycol (mol. wt. 2000, Fluka) treatment as described (Polanski,
1997a). The frequency of GVBD was scored 1 h after fusion. The entire
procedure was performed in the presence of dbcAMP to prevent spontaneous
GVBD in the reporter oocyte.
Biological assay of CSF activity
Oocyte halves were fused with parthenogenetically activated mouse eggs or
zygotes, and CSF activity was determined based on the extent of arrest of the
activated eggs in the metaphase of the first mitotic division after fusion
(Zernicka-Goetz et al., 1995). MII oocytes obtained after superovulation (Nagy
et al., 2003) of CD-1 mice were parthenogenetically activated by exposure to
ethanol (Zernicka-Goetz et al., 1995). Zygotes were obtained by mating
superovulated females with F1 (C57BlXDBA) males. 13–15 h after ethanol
treatment (parthenogenotes) or 26–29 h post hCG injection (zygotes) the one-
cell eggs were agglutinated and fused with oocyte halves as described above.
The number of fused eggs arrested at metaphase was scored 24 h after fusion.
Western blots
Samples were collected 6 h after GVBD in 5 μl of Laemmli buffer
(Laemmli, 1970) and boiled for 3 min. Lysates were resolved on a 12.5%
polyacrylamide (acrylamide:bisacrylamide, 100:1) gel and transferred to a
nitrocellulose membranes (Amersham, Hybond-ECL). After blocking with
Blotto A (Santa Cruz Biotechnology) for 1 h, the membrane was incubated for at
least 2 h with anti-cyclin B1 antibody GNS-1 (Santa Cruz Biotechnology) or the
anti-CDK1 monoclonal antibody A17 (gift from J. Gannon, CRUK, Clare Hall
Laboratories) diluted 1:100 or 1:200, respectively, in Blotto A, washed three
times in TBST (20 mMTris–HCl (pH 7.5), 250 mMNaCl, 0.1% Tween 20), and
incubated for an additional 1 h with a HRP-conjugated secondary antibody
(Santa Cruz Biotechnology) diluted 1:1000 in Blotto A. After three washes with
TBST, the membrane was incubated in Chemiluminescence Luminol Reagent
(Santa Cruz Biotechnology).
Cyclin B1 immunoprecipitation
At about the time of GVBD (1–2 h after release from the dbcAMP block),
oocyte halves were placed in M2 medium containing 500 μCi/ml [35S]
methionine (Amersham, Redivue Pro Mix L- [35S] in vitro cell labeling mix),
and, in some experiments, lactacystin, and cultured for 5 h in 37°C. After 3
washes in PBS, halves were lysed by vortexing in 50 μl of ice-cold IP buffer (20
mM Tris–HCl, pH 7.5, 30 mM β–glycerolphosphate, 10 mM EGTA, 5 mM
MgCl2, 50 mM KCl, 1 mM DTT, 1 mM PMSF, and 0.1% Nonidet P-40)
supplemented with 10 μg/ml leupeptin and pepstatin, and 2 μg/ml aprotinin. The
lysates were centrifuged at 14000 rpm for 15 min at 4°C.
Anti-cyclin B1 antibody H-433 or GCN-1 was covalently coupled to
protein A-beads (Bio-Rad, 5 mg/1 ml beads) using dimethylpimelimidate
dihydrochloride (Sigma) as described (Schneider et al., 1982). For
immunoaffinity purification, 2–3 μl of the antibody-coupled beads were
incubated with 50 μl of oocyte extract for 3 h. Beads were washed several
times with ice-cold IP wash buffer (IP buffer supplemented with 200 mM
KCl), and bound material was released by boiling in Laemmli sample buffer
for 3 min and briefly centrifuged. Proteins were resolved on a 12.5%
polyacrylamide (acrylamide:bisacrylamide, 100:1) gel, and transferred to a
nitrocellulose membrane (Amersham, Hybond-ECL). Labeled proteins were
visualized by exposure to a Fuji BAS2000 bioimager (Fuji). The co-
immunoprecipitated CDK1 was detected by Western blotting using
monoclonal antibody A17.
Table 1
Characterization of luciferase constructs injected into oocytes
5′UTR insert 3′UTR poly A 30
pRN3 F/F Globin F/F Globin Yes
pBS F/F 1 Globin F/F No UTR Yes
pBSF/F 2 Globin F/F Cyclin B1 Yes
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The mRNA was collected from whole oocytes or corresponding doubled
number of oocyte halves using Qiagen RNeasy Mini kit (Qiagen) following
the manufacturer's instruction. The number of oocytes/halves in individual
experiments varied between 16/32 and 22/44. cDNA was made from the
purified mRNA using the Invitrogen Superscript II Reverse Transcriptase kit
(Invitrogen) on 8 μl of template RNA following the protocol provided by
manufacturer. The Real Time PCR was performed on a Roche Real-Time
Light Cycler system (Roche). A standard curve was generated with serial
dilutions of plasmid containing cyclin B1 linearized by restriction enzyme
digest to avoid supercoiling. Primers used were 5′-TGG ACTACG ACATGG
TGC AT-3′ and 5′-CTT TGT GAG GCC ACA GTT CA-3′. For the reaction
the Roche LightCycler – FastStart DNA Master SYBR Green I kit was used
(Roche). The pre-incubation, amplification (annealing temp. 55°C) and
melting curve analysis were done according to the manufacturer's instruction.
Plasmids
To assess translational activity, reporter constructs were prepared with firefly
luciferase (F/F) as a marker gene and different 3′UTR sequences (Table 1). For
pRN3 F/F, the F/F NcoI–XbaI cDNA fragment was subcloned from pGL3
control into pRN3, which has an MCS flanked by the globin 5′ and 3′UTR. For
pBS F/F1, a poly-A adaptor encoding 30 A's was ligated into the BglII site of
pBS vector with a modified MCS, creating pBS pA30, and the HindIII–XbaI
fragment of the F/F including the globin 5′UTR from pRN3 F/F was subcloned
into this vector. For pBS F/F 2, the cyclin B1 3′UTR fragment was amplified
from the IMAGE clone (IMAGp998J179258Q) by PCR and inserted into pBS F/
F1 at the XbaI–NotI sites introduced.
RNA synthesis
Vectors were cut using SfiI (for pRN3 F/F) or SalI (for pBS F/F1 and 2)
and purified using a gel extraction kit (QIAGEN). Capped mRNA was
produced using T3 Message Machine (AMBION) and purified using the
RNeasy kit (QIAGEN).
Luciferase assay
Oocyte halves were sampled individually at the end of the culture period
(18–22 h) and frozen. Firefly luciferase signal intensity was determined using
the Dual-Luciferase Reporter Assay System kit (Promega) according to the
protocol provided by manufacturer. Signal intensity was measured using a
Wallac 1410 luminometer (Perkin Elmer). The signal intensity varied reasonably
in halves originating from different oocytes. One of the contributing factors was
certainly the inability to control precisely the amount of injected RNA. To avoid
the variability caused by the unequal amounts of RNA received by individual
oocytes, we estimated the relative difference between nuclear and anuclear
halves in their translational activity by calculating the ratio of the signal from the
nuclear half to that from the anuclear half for each sister pair of halves.
Results
MPF/histone H1 kinase and CSF/MAP kinase in nuclear and
anuclear oocyte halves
The activity of histone H1 kinase, reflecting the activity of
MPF, showed a profile in nuclear halves that was typical formaturing oocytes (e.g., Choi et al., 1991; Kubiak et al., 1992),
peaking at both meiotic metaphases with a transient inactivation
at the time of first polar body extrusion. Anuclear halves
showed the same kinetics of histone H1 kinase activity as their
nuclear counterparts until 2 h after GVBD, when no further
increase in this activity was detected (Fig. 1A). At the MI and
early MII stage the histone H1 kinase activity detected in
anuclear halves reached only 28% and 34% of the activity
observed respectively in their nuclear counterparts (difference
statistically significant). Thus, full activation of MPF requires
GV material. By contrast, the pattern of MBP kinase activity,
reflecting MAP kinase activity, was essentially the same in both
types of halves (Fig. 1B) and typical of that observed in intact
oocytes (e.g., Verlhac et al., 1993, 1994). Western blot analysis
of nuclear and anuclear halves and intact oocytes revealed an
up-shift in the bands corresponding to ERK1 and ERK2 MAP
kinases in each case (Fig. 1C), with a slightly higher, but
statistically non-significant, degree of up-shift in the presence of
a nucleus (Fig. 1D). Up-shift of these enzymes is associated
with activation linked directly to their phosphorylation (Verlhac
et al., 1993).
In a biological assay of MPF activity, anuclear and nuclear
halves were fused with an oocyte blocked at the GV stage, whose
behavior served to distinguish between MPF-containing and
MPF-deprived cytoplasm of the oocyte halves. After fusion, the
majority of nuclear halves, but none of the anuclear halves,
induced GVBD in the reporter oocyte (Table 2). These results are
consistent with the histone H1 kinase activity measurements.
In another series of fusion experiments, CSF activity was
tested in anuclear and nuclear oocyte halves fused respectively
to parthenogenetically activated mouse 1-cell embryos as a
reporter of CSF activity in the cytoplasm of the respective
halves. In such conditions CSF delivered by the oocyte
cytoplasm arrests the majority of the hybrid cells in the M-
phase (Zernicka-Goetz et al., 1995). After fusion, anuclear and
nuclear oocyte halves induced metaphase arrest with the same
high efficiency (Table 3), suggesting high CSF activity in both
cases and consistent with the presence of active ERK1 and
ERK2 MAP kinases in both types of halves. To verify that
metaphase arrest was caused by CSF and not other putative
factors able to arrest the cell cycle progression we fused oocyte
halves to zygotes. Oocyte/zygote hybrids were reported to
rarely arrest in M-phase (23–28%; Zernicka-Goetz et al., 1995)
since the pronuclei of fertilized eggs, in contrast to pronuclei of
parthenogenotes, generate calcium waves destroying CSF
(Kono et al., 1995). Consistently, the frequency of M-phase
arrest dropped from 69% in the hybrids composed from oocyte
halves and parthenogenotes to 30–31% in the hybrids
composed from oocyte halves and zygotes (Table 3; the
decrease statistically significant for both nuclear and anuclear
halves, χ2 test of independence). These data confirm that M-
phase arresting activity present in oocyte halves is CSF-related.
Cyclin B1 and CDK1 in nuclear and anuclear oocyte halves
Western blot analysis to evaluate the distribution of molecular
components of MPF in the anuclear and nuclear halves revealed
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metaphase, 6 h after GVBD, whereas CDK1 kinase was
similarly abundant in both types of halves (Fig. 2A). Thus, the
reduced activity of MPF in anuclear halves appears to reflect a
deficiency of cyclin B1. In the immature mouse oocyte, only a
limited pool of cyclin B1 is stored and at the onset of maturation
cyclin B1 synthesis switches on and level of the protein
progressively increases (Hampl and Eppig, 1995; Polanski et al.,
1998). Thus, the possible explanation for the difference found in
the amount of cyclin B1 in the oocyte halves might rest in the
deficient new cyclin B1 synthesis in the absence of GVmaterial.
Alternatively, the observed difference in the cyclin B1
amount in the oocyte halves could result from an unequal
distribution of this protein stored in the immature oocyte, in
case it is preferentially localized in the GV or GV-adjacent
cytoplasm. However, the nucleus in the somatic prophase cells
(Pines and Hunter, 1991; Hagting et al., 1998) as well as in the
mouse oocytes maintained at GV stage with dbcAMP
(Marangos and Carroll, 2004) actively exclude cyclin B1 to
the cytoplasm, which results in clear deficiency of this protein in
the GV (Ledan et al., 2001; Marangos and Carroll, 2004).
Moreover, Marangos and Carroll (2004) observed in mouse GV
stage oocytes an uniform distribution of cyclin B1-GFP
throughout the cytoplasm with only one to two tiny accumula-
tions close to GV membrane representing most probably
microtubule-organizing centers. It is unlikely that in our
nucleate halves, this slight cyclin B1 enrichment close to the
nuclear membrane could compensate for the deficiency of this
protein in the GV (compare the cyclin B-GFP signal from GV
and from the perinuclear region in Fig. 3A in Marangos and
Carroll, 2004). This prompted us to exclude the hypothesis that
anuclear halves of oocytes bisected at GV stage possess lower
amount of cyclin B1 before resuming maturation. Finally, this
was strongly supported by the observation that there was no
difference in MPF activity in the two types of halves at the
initial phase of maturation when MPF depends on the cyclin B1
stored in immature oocyte (Fig. 1A). The difference in MPF
activity appeared only later (Fig. 1A) during the period when
this activity depends largely on new cyclin B1 synthesis (Hampl
and Eppig, 1995; Ledan et al., 2001). For all these reasons we
have focused on the regulation of cyclin B1 translation in both
types of halves during maturation.Fig. 1. Activity of histone H1 kinase and MBP kinase during maturation of
oocyte halves. Filled squares, nuclear halves; open squares, anuclear halves.
Data are given as mean ± SD. (A) Activity of histone H1 kinase; 2–6
determinations per time point except for PB1 and late MII (one determination).
Values marked with the same superscript differ significantly from each other
(ANOVA): aP b 0.02; bP b 0.05. PB1—first polar body extrusion, MI—
metaphase I, MII—metaphase II. (B) Activity of MBP kinase; 2–6 determina-
tions per time point. Data are given as mean ± SD. (C) Activation-associated
phosphorylation of ERK proteins during maturation of both types of halves. The
gel on the left shows the status of ERK proteins in whole oocytes. The gel on the
right (representative of four performed independently) shows the status of ERK
proteins in oocyte halves. (D) Quantification of the fraction of ERK proteins
undergoing phosphorylation at metaphase I (measured as the percent of the ERK
proteins undergoing mobility shift). Each bar represents measurement done in
four independent experiments. The differences between all groups are
statistically nonsignificant (ANOVA). Data are given as mean ± SD.Immunoprecipitation analysis of cyclin B1 synthesis in
oocyte halves during the first meiotic M-phase revealed that the
anuclear, but not the nuclear halves, exhibit a marked deficiency
in the amount of newly synthesized cyclin B1 (Figs. 2B, C). We
did not detect any distinct differences in the amount of
radiolabeled proteins present in the supernatant after cyclin
B1 immunoprecipitation (Figs. 2B, C), which indicates that the
global level of protein synthesis in both types of halves is
Table 2
MPF activity in nuclear and anuclear oocyte halves matured in vitro
Type of
fusion
No. of
experiments
No. of
hybrids
No. (%) of hybrids in
M-phase a (GVBD)
Anuclear half:
GV oocyte
4 27 0 (0%)
Nuclear half:
GV oocyte
4 33 23 (70%)
a Checked 1 h after fusion.
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cyclin B1.
The amount of cyclin B1 during meiotic maturation is
regulated through both the synthesis and degradation of this
protein (Ledan et al., 2001; Hyslop et al., 2004), raising the
possibility that the difference between halves could also result
from a precocious degradation of cyclin B1. This possibility
seemed quite plausible since the absence of chromosomes in
anuclear halves would abrogate any role for active spindle
assembly checkpoint that normally inhibits degradation of
cyclin B1 upon interactions of kinetochores and microtubule
fibers. Therefore, we decided to use the proteosome inhibitor
lactacystin, which is known to inhibit cyclin B1 degradation in
rat oocytes (Josefsberg et al., 2000). First, to confirm that
lactacystin has the same effect in mouse oocytes as in the rat we
have tested the combined effect of lactacystin and puromycin on
histone H1 kinase activity in maturing oocytes. To this end
maturing oocytes at metaphase I stage were transferred to
puromycin containingmedium or to themedium containing both
puromycin and lactacystin and cultured overnight. As expected,
the oocytes cultured in the presence of puromycin extruded the
first polar body and exhibited low level of histone H1 kinase
activity at the end of culture period (Fig. 3A). This resulted from
cyclin B degradation occurring at the time of first meiotic
division combined with protein synthesis inhibition preventing
accumulation of any newly synthesized protein, cyclins
included. On the other hand, the oocytes cultured in the presence
of puromycin and lactacystin did not extrude the polar body and
their histone H1 kinase activity remained high (Fig. 3A) whichTable 3
CSF activity in nuclear and anuclear oocyte halves matured in vitro
Type of fusion No. of
experiments
No. of
hybrids
No. (%) of hybrids
arrested in metaphase a
Anuclear half:
parthenogenote
4 26 18 (69)
Nuclear half:
parthenogenote
4 26 18 (69)
Anuclear half:
zygote
3 23 7 (30)
Nuclear half:
zygote
3 16 5 (31)
Parthenogenote:
parthenogenote
4 14 1 (7)
Zygote: zygote 2 10 0 (0)
MII oocyte:
MII oocyte
5 14 14 (100)
a Checked 24 h after fusion.
Fig. 2. Cyclin B1 during maturation of oocyte halves. (A) The amount of cyclin
B1 but not of CDK1 is markedly reduced in anuclear halves (representative gel
from 3 independent experiments). (B, C) Anuclear halves show reduced levels
of cyclin B1 synthesized during first meiotic M-phase as revealed by
immunoprecipitation of 35S-labeled proteins using the cyclin B1-specific
antibodies GNS-1 (B) and H-4333 (C); one determination for each antibody.
(C) CDK1 co-precipitated by H-433 is also shown.shows that these oocytes remained arrested at the first meiotic
metaphase due to inhibition of cyclin B degradation. We then
examined cyclin B1 accumulation by Western blotting in the
oocyte halves incubated in lactacystin alone. In the presence of
the drug, a clear difference in the levels of cyclin B1was retained
Fig. 4. Relative amounts of cyclin B1 mRNA present at GV stage in nuclear and
anuclear oocyte halves as well as in whole oocytes. Data are given as mean ± SD
(four independent experiments). The differences between all groups are
statistically nonsignificant (ANOVA).
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anuclear halves does not reflect enhanced degradation but,
instead, decreased translation of the protein.
The amount of cyclin B1 mRNA is similar in nuclear and
anuclear oocyte halves
The difference described above could come either from the
unequal distribution of cyclin B1 mRNA, or from the different
efficiency of translation of equally distributed mRNA. To verify
this, we have measured the relative amounts of cyclin B1
mRNA in nuclear and cytoplasmic halves produced from
oocytes arrested at the GV stage by dbcAMP. The anuclear
halves contained only 16% of cyclin B1 mRNA less than the
nuclear halves (Fig. 4). This slight difference is statistically
nonsignificant and indicates that distinct differences in MPF
activity and cyclin B1 protein level in both types of halves
reflect different efficiency of translation of similar amount of
cyclin B1 mRNA present in both types of halves.
3′UTR of cyclin B1 mRNA and translational activity in nuclear
and anuclear oocyte halves
To further address the mechanism of GV-dependent
translational control of cyclin B1, we monitored the fluores-
cence signal intensity of oocytes that were injected at GV stage
with one of three different luciferase reporter constructs (see
Table 1), bisected, and allowed to mature in culture. The signal
from each construct was consistently stronger in nuclear
halves, but the enhancement of the expression in nuclear halvesFig. 3. Reduced level of cyclin B1 does not result from its precocious
degradation. (A) Lactacystin treatment inhibits protesome activity and prevents
cyclin B1 degradation in maturing mouse oocytes as revealed by maintaining
high level of histone H1 kinase activity in oocytes undergoing first meiotic
division in the presence of puromycin and lactacystin. Samples collected at GV,
GVBD + 2 h, (2), GVBD + 4 h (4), GVBD + 6 h (6) and after overnight culture
with puromycin added at GVBD + 6 h (ON + P). See detailed description of
experiment in the text. Representative gel of two separate experiments is shown.
(B) The amount of cyclin B1 is markedly reduced in anuclear halves maturing in
the presence of lactacystin (representative gel of 2 experiments).was much greater for the construct containing cyclin B1-
specific 3′UTR as compared with the constructs respectively
containing globin-specific 3′UTR or no 3′UTR sequence
(Table 4). Thus, the GV-dependent control of translation in
maturing oocytes is at least partially dependent on the cyclin
B1 3′UTR.
Discussion
In this study, we find that the activity of MPF, but not of
MAP kinases ERK1 and ERK2 or CSF, during mouse oocyte
maturation depends on material located in the GV of prophase
oocytes. Our findings are in apparent contrast with those of
Balakier and Czolowska (1977). They used a semi-quantitative
biological assay to show that both the nuclear and anuclear
oocyte halves efficiently induced entry into M-phase and
premature chromosome condensation (PCC) when fused to 2-
cell blastomeres within 2 h after GVBD (Balakier and
Czolowska, 1977). Based on those findings, the authors
concluded that MPF activity is GV-independent throughout
the entire maturation process. Our results show that until 2
h after GVBD, the MPF activity in anuclear halves does indeed
correspond to that exhibited by their nuclear counterparts;
however, we find a clear arrest in the further increase in MPF
activity starting around 2 h after GVBD in anuclear halves, with
levels not even half those of nuclear halves when measured at
metaphase I and II. Based on the data from both studies, we
conclude that the initial activation of MPF, sufficient to induce
M-phase entry, is independent of GV material; however, the
profile of the activity throughout the entire period of oocyte
maturation is strictly GV-dependent.
The GV stage of the mouse oocyte corresponds to the G2/M
phase of a somatic mitotic cell. In mitotic cells progression
through the whole but relatively short (about 1 h) M-phase is
ensured by the pool of cyclin B accumulated during late G2, i.e.,
before entry into M-phase. However unlike mitotic cells, GV-
stage mouse oocytes have only a limited pool of cyclin B1
(Hampl and Eppig, 1995; see also Fig. 2A in this study), and
successful completion of the first meiotic cycle requires
intensive cyclin B1 synthesis throughout M-phase (Hampl and
Table 4
Translational activity of cyclin B1 synthesis during meiotic maturation of oocyte halves
3′UTR of injected
luciferase RNA
Halves produced Luciferase ratio (nuclear/anuclear halves) at
GV MII
N Mean ± SD Median N Mean ± SD Median
No UTR Before maturation 20 2.1 ± 2.0 1.9 20 4.7 ± 3.8a 3.4
Globin Before maturation 23 2.7 ± 2.1c 1.8 23 9.0 ± 14.7b 5.5
Cyclin B1 Before maturation 12 1.1 ± 0.7c 1.0 27 129.1 ± 217.1a,b 37.6
Cyclin B1 After maturation 14 1.3 ± 0.7 1.3 22 1.0 ± 0.3 1.1
The ratio of the intensity of luciferase signal was calculated for sister halves. Ratio at GV represents the measurements done in these pairs in which nuclear half
remained in GV stage until the end of culture. Ratio at metaphase II represents measurements in pairs in which nuclear half successfully matured in vitro (as evidenced
by first polar body extrusion). Halves produced “after maturation” represent experiments in which injected oocytes underwent maturation in vitro and were cut into
halves only after completion of this process. Values marked with the same superscript differ significantly (ANOVA, a, b, cP b 0.02). Since the great data spreading may
lead to overestimation of mean values the median values are also shown.
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synthesis is significantly accelerated soon after GVBD (Hampl
and Eppig, 1995; Winston, 1997). The activity of histone H1
kinase in oocytes induced to mature in the absence of protein
synthesis arrests at a low level after GVBD due to absence of
newly produced cyclin B1 accumulation (Hampl and Eppig,
1995; Polanski et al., 1998), and closely resembles the profile of
histone H1 kinase activity we observed here in anuclear halves.
Consistent with those observations, we find marked inhibition
of cyclin B1 translation during maturation of anuclear halves.
Together, these results demonstrate that switch-on of cyclin B1
translation in maturing oocytes requires a factor(s) released from
GV into the cytoplasm. This factor(s) is specific to the nucleus
of the oocyte or fertilized egg, since replacement of the oocyte
nucleus by the nucleus of a cumulus cell or by the nucleus of a
primary spermatocyte results in decreased levels of histone H1
kinase activity (Polanski et al., 2005). Using oocytes from two
inbred strains differing in the speed of first meiosis (Polanski,
1997b), we previously demonstrated a direct correlation
between the level of cyclin B1 synthesis and the timing of
first meiotic division, and showed that the latter is controlled by
a GV-associated factor(s) (Polanski et al., 1998). It seems likely
that the nuclear factor(s) controlling the timing of first meiotic
division is identical to that controlling cyclin B1 synthesis.
GV-dependent control of cyclin B synthesis in maturing
oocytes has been reported for starfish (Galas et al., 1993). In that
study, removal of the GV before induction of meiotic
maturation resulted in markedly reduced synthesis of cyclin B
but not of other proteins. Our comparison of the translational
activity of three different luciferase constructs in the present
study demonstrates the specific, 3′UTR-dependent, control of
cyclin B1 synthesis, although detailed information about the
degree of the specificity of this control is lacking. Translation of
proteins that are intensively synthesized during oocyte
maturation occurs through specific 3′UTR-located regulatory
sequences such as CPE (cytoplasmic polyadenylation element)
and hexanucleotide (Mendez and Richter, 2001). The mouse
oocyte has the machinery required to control CPE-dependent
translation (Hodgman et al., 2001), and translation of cyclin B1
during maturation relies on this process (Tay et al., 2000). CPE-
dependent translation of tPA (Vassalli et al., 1989; Huarte et al.,
1992) and c-mos (Gebauer et al., 1994) has also beendocumented in mouse oocytes. Further information on the
molecular mechanisms of GV-dependent translational control
awaits studies examining the effect of GV removal on the
synthesis of such proteins in mouse oocytes, combined with
analysis of translational activity of reporter constructs contain-
ing truncated/modified forms of the corresponding 3′UTR's.
After the initial demonstration that MAP kinase activation in
mouse oocytes depends on protein synthesis (Verlhac et al.,
1993), further studies showed that MPF activation precedes that
of MAP kinase (Verlhac et al., 1994, 1996) and that maximal
MPF activity is also dependent on protein synthesis (Hampl and
Eppig, 1995). Thus, it seemed likely that MAP kinase activation
could depend on MPF activity and, in the absence of protein
synthesis, the low MPF activity might not be sufficient to
activate MAP kinase. However, we observed nearly full
activation of MAP kinase in anuclear oocyte halves (compare
MBP kinase activity as well as the extent of ERK1 and ERK2
up-shift in the halves and in intact oocytes in Figs. 1B–D).
Thus, at similar low activity of MPF, the MAP kinases ERK1
and ERK2 are activated in anuclear halves but not in oocytes
maturing in the absence of protein synthesis. This suggests that
the requirement of protein synthesis for MAP kinase activity is
not linked to MPF but to synthesis of another protein(s), e.g.,
some unidentified phosphatase(s) known to influence this
process (Verlhac et al., 1993).
In mature MII-arrested oocytes, as well as in nuclear halves,
high MAP kinase activity is correlated with the high activity of
MPF/histone H1 kinase. Thus, high activity of both MAP
kinase and MPF might be required for the CSF activity.
However, our biological test for CSF activity showed that
despite low MPF activity throughout maturation and at MII in
anuclear halves, these latter had equally high CSF activity as
nuclear halves. Thus, high activity of MPF does not appear to be
required for the development or maintenance of CSF activity in
mouse oocytes.
A single study in Xenopus reported the existence of GV-
associated factor(s) that affects MPF activity in maturing
oocytes (Iwashita et al., 1998), although Fisher and colleagues
(1998) have questioned the findings. In the Xenopus study,
enucleated oocytes activated MPF to a lesser extent in the first
meiotic M-phase and not at all in the second meiotic M-phase
(Iwashita et al., 1998), suggesting that similar to our findings in
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full activity of MPF. However, we find that such a nuclear factor
(s) in the mouse oocyte mediates its function by activating and/
or increasing cyclin B1 synthesis. This is similar to findings in
starfish oocytes (Galas et al., 1993), whereas Iwashita and
colleagues (1998) reported that the low activity of MPF in GV-
deprived Xenopus oocytes was associated with lack of CDK1
kinase phosphorylation, with no effect on cyclin B synthesis.
The molecular mechanism(s) underlying the nuclear control of
MPF activity during oocyte maturation in axolotl (Gautier,
1987) and Pleurodeles (Skoblina et al., 1984) remains obscure.
It also remains unclear how oocytes would benefit from GV-
associated control of MPF activity during maturation. Never-
theless, such a control presumably has an important function,
since it evolved in several different species and possibly by
different mechanisms (compare our results on cyclin B1
synthesis with those of Iwashita and colleagues, 1998). A
recent report in starfish suggests the presence of an unidentified
GV-located inhibitor of PP1 phosphatase, which is released into
the oocyte cytoplasm upon GVBD and is required for activation
of CPE-dependent translation of cyclin B (Lapasset et al.,
2005). It remains to be determined whether a similar mechanism
operates in mouse oocytes. In both starfish and mouse, however,
this GV-associated control of cyclin B synthesis would ensure a
perfect temporal regulation of translation of this protein by
maintaining cyclin B at low levels over the enormously long
period of prophase arrest and up-regulating its synthesis only
for the period of meiotic maturation and metaphase II-arrest,
when it is required in large quantities. In Xenopus, where GV
control of MPF activity does not appear to involve changes in
cyclin B synthesis (Iwashita et al., 1998), the function of such
control remains controversial.
Note added in proof
In two recent studies, the meiotic maturation of porcine
oocytes after GV removal was investigated. Whereas one group
(Ogushi et al., 2005) did not find any influence of GV removal
on MPF activity, Sugiura et al. (in press) reported that in the
porcine oocytes GV material influences MPF activity during the
late phase of maturation by inhibiting accumulation of cyclin B
after completing first meiotic division.
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